recurrent pterygial cells than on primary ones. Our small prospective interventional study documented favorable outcomes of the use of topical MMC in the management of acutely recurring pterygium. It effectively halted progression and led to regression of the growth, avoiding the need for repeat surgical excision. However, larger clinical trials are warranted to evaluate the long-term safety an...

Purpose: To compare the outcome of amniotic membrane transplantation (AMT) versus autologus limbal stem cell transplantation (LSCT) in the management of recurrent pterygium. Setting: Suez Canal University Hospital, Ophthalmology Department, Ismailia, Egypt. Methods: This is a comparative prospective case series study included forty two eyes with recurrent pterygia. They were equally and randoml...

PURPOSE The pathogenesis of pterygia is still not well understood. Recent studies suggest that it may be associated with inflammation and progressive proliferation triggered by ultraviolet radiation. In this study the authors determined that the inflammatory nature of pterygium is reflected in the protein components of tears. METHODS Consent for this study was obtained from 12 patients (avera...

ptk (phototherapeutic keratectomy) is the use of laser in corneal diseases. we can replace ptk for many other invasive procedures. the objective of this study is the assessment of this procedure in several cases in our practice. this investigation was a retrospective study, which was conducted based on comparison of 11 eyes with corneal eschars, induced by recurrent corneal erosions, pterygium ...

AIMS To evaluate the success rates of conjunctival autografting for primary and recurrent pterygium performed in a tertiary ophthalmic centre. METHODS The outcome of 139 cases with primary pterygia and 64 cases with recurrent pterygia who underwent excision with conjunctival autografting was retrospectively reviewed. Outcome was evaluated in terms of recurrence of pterygia onto the cornea. Th...

OBJECTIVES To estimate the frequency of unsuspected ocular surface squamous neoplasia (OSSN) in pterygium, the accuracy of clinical diagnosis, and associated demographic and clinical characteristics. MATERIALS AND METHODS We reviewed histopathological reports of patients with a clinical diagnosis of pterygium and/or OSSN who were surgically treated between March 2009 and December 2012 at the ...

The treatment of ocular pterygium has been subjected to the development and application of various new strategies in the last few years. The worrisome problem of recurrence seems to have been significantly reduced with the newer methods of treatment. The field is however, still evolving. This review sets out to examine the various newer approaches to treating pterygium and in spite of the recen...

PURPOSE We report on the use of subconjunctival bevacizumab on corneal vessel density in recurrent pterygia. METHODS The charts of 5 patients with recurrent pterygium, who received subconjunctival injections of bevacizumab (2.5 mg/0.1 ml) were retrospectively reviewed. Ophthalmic evaluation included Snellen visual acuity (VA), tonometry and complete examination before the injection and at 1 w...